

> the programmable brain @ JPM Healthcare 2027
Our ability to observe and interface with the brain is advancing at an extraordinary pace. Yet we have not been able to translate these advances into treatments for neurological and psychiatric disorders. How can we move from recording and modelling neural activity to understanding and precisely controlling dysfunctional neural circuits? And what will it take to turn these capabilities into therapies that restore brain function?
Join us during JPM Healthcare Week for The Programmable Brain, an evening bringing together leading scientists, founders and investors to explore the scientific breakthroughs and emerging technologies that could transform our ability to understand, interface with and ultimately treat the brain.
Speakers
Alan Mardinly, Co-founder & CSO, Science Corporation
Adam Marblestone, Co-founder, Convergent Research
Sumner Norman, Co-founder, Merge Labs
Andreas Tolias, Professor, Stanford University
The discussion will be followed by a drinks reception.
Hosted by Exin Therapeutics.
Sponsored by Morrison Foerster.